SightfileU.S. market data from official filings

SEPTERNA INC (SEPN)

Name: SEPTERNA INC (SEPN) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001984086 · EDGAR filings · Updated 2026-07-17

SEPTERNA INC (SEPN) has reported institutional ownership of 101.8%, with 124 institutional managers holding positions valued at $1.10B per the latest 13F reporting period.

Institutional ownership

101.8%

Institutional managers

124

Reported 13F value

$1.10B

Insider activity

14 trans.

−$2.16M net selling

Latest updates

2026-07-17 — Insider transaction reported (Form 4)
2026-07-15 — Notice of proposed sale filed (Form 144)
2026-07-02 — Insider transaction reported (Form 4)
2026-06-30 — Insider transaction reported (Form 4)
2026-06-30 — Insider transaction reported (Form 4)
2026-06-30 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SEPTERNA INC has 124 institutional holders and institutional ownership of 101.8%.

Insider activity

Insiders reported 14 transactions (0 buys, 5 sells) across 5 reporting insiders, with a net reported value of −$2.16M.

Related companies

GENERATE BIOMEDICINES INC (GENB) · EYEPOINT INC COM NEW (EYPT) · PHIBRO ANIMAL HEALTH CORP (PAHC) · ZENAS BIOPHARMA INC (ZBIO) · AURINIA PHARMACEUTICALS INC (AUPH) · NOVOCURE LTD (NVCR)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.